16680-50-5 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1] Patent: US2017/29430, 2017, A1, . Location in patent: Paragraph 0255
Reference: [1] Patent: US7235559, 2007, B1,
Reference: [1] Patent: US2016/243100, 2016, A1,
Reference: [1]Gilissen; Bormans; De Groot; Verbruggen
[Journal of labelled compounds and radiopharmaceuticals, 1999, vol. 42, # 13, p. 1289 - 1300]
Reference: [1]Journal of Medicinal Chemistry,2002,vol. 45,p. 1300 - 1312
[2]Patent: EP1244647,2006,B1 .Location in patent: Page/Page column 19
[3]Patent: WO2007/36713,2007,A2 .Location in patent: Page/Page column 57
[4]Patent: US2010/75916,2010,A1 .Location in patent: Page/Page column 19-20
[5]Patent: CN108558828,2018,A .Location in patent: Paragraph 0076; 0101-0102
Reference: [1]Li, Qiannan; Zhang, Tao; Li, Shiliang; Tong, Linjiang; Li, Junyu; Su, Zhicheng; Feng, Fang; Sun, Deheng; Tong, Yi; Wang, Xia; Zhao, Zhenjiang; Zhu, Lili; Ding, Jian; Li, Honglin; Xie, Hua; Xu, Yufang
[ACS Medicinal Chemistry Letters, 2019, vol. 10, # 6, p. 869 - 873]
[2]Current Patent Assignee: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY; CHINESE ACADEMY OF SCIENCES; Shanghai Institute of Materia Medica (in: CAS) - EP3778586, 2021, A1
Location in patent: Paragraph 0060-0061
[3]Boschelli, Diane H.; Ye, Fei; Wu, Biqi; Wang, Yanong D.; Barrios Sosa, Ana Carolina; Yaczko, Deanna; Powell, Dennis; Golas, Jennifer M.; Lucas, Judy; Boschelli, Frank
[Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 21, p. 3797 - 3800]
* For details of the synthesis route, please refer to the original source to ensure accuracy.